계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Ultivue
company
About
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20M
- Industries
- Biopharma,Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and will eventually be valuable for clinical diagnostic use. It was founded in 2015 and headquartered in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$97.15M
Ultivue has raised a total of
$97.15M
in funding over 2 rounds. Their latest funding was raised on
Apr 27, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 27, 2021 | Series D | $50M | 1 | — | — | Detail |
| Jun 14, 2019 | Series C | $22M | 1 | — | — | Detail |
| Jan 23, 2018 | Series B | $20M | 1 |
ARCH Venture Partners
|
— | Detail |
| Oct 13, 2015 | Series A | $5.15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Ultivue is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
